Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Chemotherapy With Autologous HPC Transplant for Multiple Sclerosis
NCT01679041Phase 2Terminated
- Sponsor
- Seah Lim
- Start
- Nov 2012
- Primary completion
- Nov 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous hematopoietic progenitor cells in multiple sclerosis (MS), sponsored by Seah Lim. Started Nov 2012; status: terminated.
02
Drugs
autologous hematopoietic progenitor cells
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01679041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01679041.